222

I'ROM GROUP CO LTD

No trades
See on Supercharts

2372 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

I'rom Group Co., Ltd. engages in the medical support business. It operates through the following business divisions: Advanced Medicinal Treatment Services, Site Management Organization (SMO) Services, Contract Research Organization (CRO) Services and Medical Support Business. The Advanced Medicinal Treatment Services division engages in the development of advanced medical technologies such as regenerative medicine and gene therapy to the practical level has been long awaited. The SMO services division conducts clinical trials, various operations, besides examinations and tests, arise at the medical institutions, including data organization and document management. The CRO Services division provides clinical trials of pharmaceuticals or medical devices in the development stage or in post-marketing clinical trials. The Medical Support Business division supports the enhancement of convenience and quality of medical care for patients by providing clinic malls. The company was founded on April 9, 1997 and is headquartered in Tokyo, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

2372 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company